Notice Information
Notice Title
NHSE1088 - Mpox Vaccination and Gonorrhoea Vaccination
Notice Description
NHS England - North East and Yorkshire (the Relevant Authority) intends to award these contracts under the Direct Award Process B under the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to these awards. Following the government's acceptance of the Joint Committee on Vaccination and Immunisation (JCVI) advice that the NHS should implement: * a routine mpox pre-exposure vaccination programme building on the existing offer JCVI statement on mpox vaccination as a routine programme - GOV.UK * a routine opportunistic gonorrhoea vaccination programme JCVI advice on the use of meningococcal B vaccination for the prevention of gonorrhoea - GOV.UK The Relevant Authority is now seeking suitable providers by no later than 01 September 2025 necsu.psrprocurement@nhs.net to deliver the vaccinations alongside existing vaccination programmes (HPV GBMSM) delivered in place-based Local Authority commissioned sexual health services. Providers must deliver sexual health services in identified localities and work with partners to ensure effective programme coverage and equity of access to the local eligible population. The JCVI advised that the vaccination programmes, which have similar eligibility criteria, should primarily target gay, bisexual and other men who have sex with men (GBMSM) who meet the eligibility criteria and are at highest risk of exposure to Mpox and Gonorrhoea. There may also be a small number of individuals other than GBMSM with a similar risk of infection as the eligible GBMSM groups who can be offered the vaccines. Individuals should be identified through sexual health services using markers of high risk of infection. This includes a recent history of multiple sexual partners or recent bacterial sexually transmitted infection. Full details on the eligible cohorts for each programme are available in the service specifications for each programme. Funding of PS10.06 will be provided for each dose of vaccine delivered to members of the identified cohort. An additional PS8.00 per vaccination delivered will be provided in 2025/26 to support mobilisation. This additional implementation payment will be reviewed in advance of 2026/27 contract year. As these are newly developed programmes, no baseline activity level for these vaccinations is available. Activity delivered in 2025/26 will be used to determine an Indicative Activity Plan for 2026/27 and future contract years. Providers should build on the existing delivery of vaccinations including HPV GBMSM and the accelerated Mpox vaccination programme (where implemented) and make arrangements to deliver to the eligible population accessing their services from August 2025. Providers should be offering both vaccines by no later than 01 September 2025. Eligible providers must: * Hold a current Local Authority contract for the delivery of Sexual Health Services for one or more of the Lots/Localities as identified in this procurement process. * Pass all questions within the Regulation 20 questionnaire parts 1 and part 2 and the associated quality and financial stability assessment in part 3 of the questionnaire. To commence in August 2025 and providers should be offering both vaccines by no later than 01 September 2025. The contract term will be co-terminus with the Local Authority contract for Sexual Health Services as highlighted for each Location/Lot which includes any permissible extension periods which would be subject to the enactment of the Local Authority: Locations/Lots: Yorkshire & Humber: * Lot 1 - North Lincolnshire and North East Lincolnshire * Lot 2 - Hull * Lot 3 - East Riding * Lot 4 - Leeds * Lot 5 - Bradford * Lot 6 - Kirklees * Lot 7 - Wakefield * Lot 8 - Barnsley * Lot 9 - Doncaster North East and North Cumbria: * Lot 10 - Newcastle Upon Tyne
Lot Information
Lot 1 - North Lincolnshire and North East Lincolnshire
NHS England - North East and Yorkshire (the Relevant Authority) intends to award these contracts under the Direct Award Process B under the Health Care Services (Provider Selection Regime) regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to these awards. Following the government's acceptance of the Joint Committee on Vaccination and Immunisation (JCVI) advice that the NHS should implement: * a routine mpox pre-exposure vaccination programme building on the existing offer JCVI statement on mpox vaccination as a routine programme - GOV.UK * a routine opportunistic gonorrhoea vaccination programme JCVI advice on the use of meningococcal B vaccination for the prevention of gonorrhoea - GOV.UK The Relevant Authority is now seeking suitable providers by no later than 01 September 2025 necsu.psrprocurement@nhs.net to deliver the vaccinations alongside existing vaccination programmes (HPV GBMSM) delivered in place-based Local Authority commissioned sexual health services. Providers must deliver sexual health services in identified localities and work with partners to ensure effective programme coverage and equity of access to the local eligible population. Eligibility The JCVI advised that the vaccination programmes, which have similar eligibility criteria, should primarily target gay, bisexual and other men who have sex with men (GBMSM) who meet the eligibility criteria and are at highest risk of exposure to Mpox and Gonorrhoea. There may also be a small number of individuals other than GBMSM with a similar risk of infection as the eligible GBMSM groups who can be offered the vaccines. Individuals should be identified through sexual health services using markers of high risk of infection. This includes a recent history of multiple sexual partners or recent bacterial sexually transmitted infection. Full details on the eligible cohorts for each programme are available in the service specifications for each programme. Activity/funding Funding of PS10.06 will be provided for each dose of vaccine delivered to members of the identified cohort. An additional PS8.00 per vaccination delivered will be provided in 2025/26 to support mobilisation. This additional implementation payment will be reviewed in advance of 2026/27 contract year. As these are newly developed programmes, no baseline activity level for these vaccinations is available. Activity delivered in 2025/26 will be used to determine an Indicative Activity Plan for 2026/27 and future contract years. Delivery date Providers should build on the existing delivery of vaccinations including HPV GBMSM and the accelerated Mpox vaccination programme (where implemented) and make arrangements to deliver to the eligible population accessing their services from August 2025. Providers should be offering both vaccines by no later than 01 September 2025. Provider Eligibility Criteria: Eligible providers must: * Hold a current Local Authority contract for the delivery of Sexual Health Services for one or more of the Lots/Localities as identified in this procurement process. * Pass all questions within the Regulation 20 questionnaire parts 1 and part 2 and the associated quality and financial stability assessment in part 3 of the questionnaire. Contract Term: To commence in August 2025 and providers should be offering both vaccines by no later than 01 September 2025. The contract term will be co-terminus with the Local Authority contract for Sexual Health Services as highlighted for each Location/Lot which includes any permissible extension periods which would be subject to the enactment of the Local Authority: Location/Lot: Yorkshire & Humber: * Lot 1 - North Lincolnshire and North East Lincolnshire - service to commence by 01 September with an expiry 31 March 2029 - with option to extend for 2-years (1+1).
Options: The contract term will be co-terminus with the Local Authority contract for Sexual Health Services as highlighted for each Location/Lot which includes any permissible extension periods which would be subject to the enactment of the Local Authority: Lot 1 - North Lincolnshire and North East Lincolnshire - service to commence by 01 September with an expiry 31 March 2029 - with option to extend for 2-years (1+1).
Lot 2 - HullNHS England - North East and Yorkshire (the Relevant Authority) intends to award these contracts under the Direct Award Process B under the Health Care Services (Provider Selection Regime) regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to these awards. Following the government's acceptance of the Joint Committee on Vaccination and Immunisation (JCVI) advice that the NHS should implement: * a routine mpox pre-exposure vaccination programme building on the existing offer JCVI statement on mpox vaccination as a routine programme - GOV.UK * a routine opportunistic gonorrhoea vaccination programme JCVI advice on the use of meningococcal B vaccination for the prevention of gonorrhoea - GOV.UK The Relevant Authority is now seeking suitable providers by no later than 01 September 2025 necsu.psrprocurement@nhs.net to deliver the vaccinations alongside existing vaccination programmes (HPV GBMSM) delivered in place-based Local Authority commissioned sexual health services. Providers must deliver sexual health services in identified localities and work with partners to ensure effective programme coverage and equity of access to the local eligible population. Eligibility The JCVI advised that the vaccination programmes, which have similar eligibility criteria, should primarily target gay, bisexual and other men who have sex with men (GBMSM) who meet the eligibility criteria and are at highest risk of exposure to Mpox and Gonorrhoea. There may also be a small number of individuals other than GBMSM with a similar risk of infection as the eligible GBMSM groups who can be offered the vaccines. Individuals should be identified through sexual health services using markers of high risk of infection. This includes a recent history of multiple sexual partners or recent bacterial sexually transmitted infection. Full details on the eligible cohorts for each programme are available in the service specifications for each programme. Activity/funding Funding of PS10.06 will be provided for each dose of vaccine delivered to members of the identified cohort. An additional PS8.00 per vaccination delivered will be provided in 2025/26 to support mobilisation. This additional implementation payment will be reviewed in advance of 2026/27 contract year. As these are newly developed programmes, no baseline activity level for these vaccinations is available. Activity delivered in 2025/26 will be used to determine an Indicative Activity Plan for 2026/27 and future contract years. Delivery date Providers should build on the existing delivery of vaccinations including HPV GBMSM and the accelerated Mpox vaccination programme (where implemented) and make arrangements to deliver to the eligible population accessing their services from August 2025. Providers should be offering both vaccines by no later than 01 September 2025. Provider Eligibility Criteria: Eligible providers must: * Hold a current Local Authority contract for the delivery of Sexual Health Services for one or more of the Lots/Localities as identified in this procurement process. * Pass all questions within the Regulation 20 questionnaire parts 1 and part 2 and the associated quality and financial stability assessment in part 3 of the questionnaire. Contract Term: To commence in August 2025 and providers should be offering both vaccines by no later than 01 September 2025. The contract term will be co-terminus with the Local Authority contract for Sexual Health Services as highlighted for each Location/Lot which includes any permissible extension periods which would be subject to the enactment of the Local Authority: Location/Lot: Yorkshire & Humber: * Lot 2 - Hull - service to commence by 01 September with an expiry 01 April 2026 with option to extend for 6-years (4+2).
Options: The contract term will be co-terminus with the Local Authority contract for Sexual Health Services as highlighted for each Location/Lot which includes any permissible extension periods which would be subject to the enactment of the Local Authority: * Lot 2 - Hull - service to commence by 01 September with an expiry 01 April 2026 with option to extend for 6-years (4+2).
Lot 3 - East RidingNHS England - North East and Yorkshire (the Relevant Authority) intends to award these contracts under the Direct Award Process B under the Health Care Services (Provider Selection Regime) regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to these awards. Following the government's acceptance of the Joint Committee on Vaccination and Immunisation (JCVI) advice that the NHS should implement: * a routine mpox pre-exposure vaccination programme building on the existing offer JCVI statement on mpox vaccination as a routine programme - GOV.UK * a routine opportunistic gonorrhoea vaccination programme JCVI advice on the use of meningococcal B vaccination for the prevention of gonorrhoea - GOV.UK The Relevant Authority is now seeking suitable providers by no later than 01 September 2025 necsu.psrprocurement@nhs.net to deliver the vaccinations alongside existing vaccination programmes (HPV GBMSM) delivered in place-based Local Authority commissioned sexual health services. Providers must deliver sexual health services in identified localities and work with partners to ensure effective programme coverage and equity of access to the local eligible population. Eligibility The JCVI advised that the vaccination programmes, which have similar eligibility criteria, should primarily target gay, bisexual and other men who have sex with men (GBMSM) who meet the eligibility criteria and are at highest risk of exposure to Mpox and Gonorrhoea. There may also be a small number of individuals other than GBMSM with a similar risk of infection as the eligible GBMSM groups who can be offered the vaccines. Individuals should be identified through sexual health services using markers of high risk of infection. This includes a recent history of multiple sexual partners or recent bacterial sexually transmitted infection. Full details on the eligible cohorts for each programme are available in the service specifications for each programme. Activity/funding Funding of PS10.06 will be provided for each dose of vaccine delivered to members of the identified cohort. An additional PS8.00 per vaccination delivered will be provided in 2025/26 to support mobilisation. This additional implementation payment will be reviewed in advance of 2026/27 contract year. As these are newly developed programmes, no baseline activity level for these vaccinations is available. Activity delivered in 2025/26 will be used to determine an Indicative Activity Plan for 2026/27 and future contract years. Delivery date Providers should build on the existing delivery of vaccinations including HPV GBMSM and the accelerated Mpox vaccination programme (where implemented) and make arrangements to deliver to the eligible population accessing their services from August 2025. Providers should be offering both vaccines by no later than 01 September 2025. Provider Eligibility Criteria: Eligible providers must: * Hold a current Local Authority contract for the delivery of Sexual Health Services for one or more of the Lots/Localities as identified in this procurement process. * Pass all questions within the Regulation 20 questionnaire parts 1 and part 2 and the associated quality and financial stability assessment in part 3 of the questionnaire. Contract Term: To commence in August 2025 and providers should be offering both vaccines by no later than 01 September 2025. The contract term will be co-terminus with the Local Authority contract for Sexual Health Services as highlighted for each Location/Lot which includes any permissible extension periods which would be subject to the enactment of the Local Authority: Location/Lot: Yorkshire & Humber: Lot 3 - East Riding - service to commence by 01 September with an expiry 31 March 2026.
Options: The contract term will be co-terminus with the Local Authority contract for Sexual Health Services as highlighted for each Location/Lot which includes any permissible extension periods which would be subject to the enactment of the Local Authority: Lot 3 - East Riding - service to commence by 01 September with an expiry 31 March 2026.
Lot 4 - LeedsNHS England - North East and Yorkshire (the Relevant Authority) intends to award these contracts under the Direct Award Process B under the Health Care Services (Provider Selection Regime) regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to these awards. Following the government's acceptance of the Joint Committee on Vaccination and Immunisation (JCVI) advice that the NHS should implement: * a routine mpox pre-exposure vaccination programme building on the existing offer JCVI statement on mpox vaccination as a routine programme - GOV.UK * a routine opportunistic gonorrhoea vaccination programme JCVI advice on the use of meningococcal B vaccination for the prevention of gonorrhoea - GOV.UK The Relevant Authority is now seeking suitable providers by no later than 01 September 2025 necsu.psrprocurement@nhs.net to deliver the vaccinations alongside existing vaccination programmes (HPV GBMSM) delivered in place-based Local Authority commissioned sexual health services. Providers must deliver sexual health services in identified localities and work with partners to ensure effective programme coverage and equity of access to the local eligible population. Eligibility The JCVI advised that the vaccination programmes, which have similar eligibility criteria, should primarily target gay, bisexual and other men who have sex with men (GBMSM) who meet the eligibility criteria and are at highest risk of exposure to Mpox and Gonorrhoea. There may also be a small number of individuals other than GBMSM with a similar risk of infection as the eligible GBMSM groups who can be offered the vaccines. Individuals should be identified through sexual health services using markers of high risk of infection. This includes a recent history of multiple sexual partners or recent bacterial sexually transmitted infection. Full details on the eligible cohorts for each programme are available in the service specifications for each programme. Activity/funding Funding of PS10.06 will be provided for each dose of vaccine delivered to members of the identified cohort. An additional PS8.00 per vaccination delivered will be provided in 2025/26 to support mobilisation. This additional implementation payment will be reviewed in advance of 2026/27 contract year. As these are newly developed programmes, no baseline activity level for these vaccinations is available. Activity delivered in 2025/26 will be used to determine an Indicative Activity Plan for 2026/27 and future contract years. Delivery date Providers should build on the existing delivery of vaccinations including HPV GBMSM and the accelerated Mpox vaccination programme (where implemented) and make arrangements to deliver to the eligible population accessing their services from August 2025. Providers should be offering both vaccines by no later than 01 September 2025. Provider Eligibility Criteria: Eligible providers must: * Hold a current Local Authority contract for the delivery of Sexual Health Services for one or more of the Lots/Localities as identified in this procurement process. * Pass all questions within the Regulation 20 questionnaire parts 1 and part 2 and the associated quality and financial stability assessment in part 3 of the questionnaire. Contract Term: To commence in August 2025 and providers should be offering both vaccines by no later than 01 September 2025. The contract term will be co-terminus with the Local Authority contract for Sexual Health Services as highlighted for each Location/Lot which includes any permissible extension periods which would be subject to the enactment of the Local Authority: Location/Lot: Yorkshire & Humber: * Lot 4 - Leeds - service to commence by 01 September with an expiry 31 March 2030 with option to extend by 4-years.
Options: The contract term will be co-terminus with the Local Authority contract for Sexual Health Services as highlighted for each Location/Lot which includes any permissible extension periods which would be subject to the enactment of the Local Authority: Lot 4 - Leeds - service to commence by 01 September with an expiry 31 March 2030 with option to extend by 4-years.
Lot 5 - BradfordNHS England - North East and Yorkshire (the Relevant Authority) intends to award these contracts under the Direct Award Process B under the Health Care Services (Provider Selection Regime) regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to these awards. Following the government's acceptance of the Joint Committee on Vaccination and Immunisation (JCVI) advice that the NHS should implement: * a routine mpox pre-exposure vaccination programme building on the existing offer JCVI statement on mpox vaccination as a routine programme - GOV.UK * a routine opportunistic gonorrhoea vaccination programme JCVI advice on the use of meningococcal B vaccination for the prevention of gonorrhoea - GOV.UK The Relevant Authority is now seeking suitable providers by no later than 01 September 2025 necsu.psrprocurement@nhs.net to deliver the vaccinations alongside existing vaccination programmes (HPV GBMSM) delivered in place-based Local Authority commissioned sexual health services. Providers must deliver sexual health services in identified localities and work with partners to ensure effective programme coverage and equity of access to the local eligible population. Eligibility The JCVI advised that the vaccination programmes, which have similar eligibility criteria, should primarily target gay, bisexual and other men who have sex with men (GBMSM) who meet the eligibility criteria and are at highest risk of exposure to Mpox and Gonorrhoea. There may also be a small number of individuals other than GBMSM with a similar risk of infection as the eligible GBMSM groups who can be offered the vaccines. Individuals should be identified through sexual health services using markers of high risk of infection. This includes a recent history of multiple sexual partners or recent bacterial sexually transmitted infection. Full details on the eligible cohorts for each programme are available in the service specifications for each programme. Activity/funding Funding of PS10.06 will be provided for each dose of vaccine delivered to members of the identified cohort. An additional PS8.00 per vaccination delivered will be provided in 2025/26 to support mobilisation. This additional implementation payment will be reviewed in advance of 2026/27 contract year. As these are newly developed programmes, no baseline activity level for these vaccinations is available. Activity delivered in 2025/26 will be used to determine an Indicative Activity Plan for 2026/27 and future contract years. Delivery date Providers should build on the existing delivery of vaccinations including HPV GBMSM and the accelerated Mpox vaccination programme (where implemented) and make arrangements to deliver to the eligible population accessing their services from August 2025. Providers should be offering both vaccines by no later than 01 September 2025. Provider Eligibility Criteria: Eligible providers must: * Hold a current Local Authority contract for the delivery of Sexual Health Services for one or more of the Lots/Localities as identified in this procurement process. * Pass all questions within the Regulation 20 questionnaire parts 1 and part 2 and the associated quality and financial stability assessment in part 3 of the questionnaire. Contract Term: To commence in August 2025 and providers should be offering both vaccines by no later than 01 September 2025. The contract term will be co-terminus with the Local Authority contract for Sexual Health Services as highlighted for each Location/Lot which includes any permissible extension periods which would be subject to the enactment of the Local Authority: Location/Lot: Yorkshire & Humber: * Lot 5 - Bradford - service to commence by 01 September with an expiry 31 March 2033.
Options: The contract term will be co-terminus with the Local Authority contract for Sexual Health Services as highlighted for each Location/Lot which includes any permissible extension periods which would be subject to the enactment of the Local Authority: Lot 5 - Bradford - service to commence by 01 September with an expiry 31 March 2033.
Lot 6 - KirkleesNHS England - North East and Yorkshire (the Relevant Authority) intends to award these contracts under the Direct Award Process B under the Health Care Services (Provider Selection Regime) regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to these awards. Following the government's acceptance of the Joint Committee on Vaccination and Immunisation (JCVI) advice that the NHS should implement: * a routine mpox pre-exposure vaccination programme building on the existing offer JCVI statement on mpox vaccination as a routine programme - GOV.UK * a routine opportunistic gonorrhoea vaccination programme JCVI advice on the use of meningococcal B vaccination for the prevention of gonorrhoea - GOV.UK The Relevant Authority is now seeking suitable providers by no later than 01 September 2025 necsu.psrprocurement@nhs.net to deliver the vaccinations alongside existing vaccination programmes (HPV GBMSM) delivered in place-based Local Authority commissioned sexual health services. Providers must deliver sexual health services in identified localities and work with partners to ensure effective programme coverage and equity of access to the local eligible population. Eligibility The JCVI advised that the vaccination programmes, which have similar eligibility criteria, should primarily target gay, bisexual and other men who have sex with men (GBMSM) who meet the eligibility criteria and are at highest risk of exposure to Mpox and Gonorrhoea. There may also be a small number of individuals other than GBMSM with a similar risk of infection as the eligible GBMSM groups who can be offered the vaccines. Individuals should be identified through sexual health services using markers of high risk of infection. This includes a recent history of multiple sexual partners or recent bacterial sexually transmitted infection. Full details on the eligible cohorts for each programme are available in the service specifications for each programme. Activity/funding Funding of PS10.06 will be provided for each dose of vaccine delivered to members of the identified cohort. An additional PS8.00 per vaccination delivered will be provided in 2025/26 to support mobilisation. This additional implementation payment will be reviewed in advance of 2026/27 contract year. As these are newly developed programmes, no baseline activity level for these vaccinations is available. Activity delivered in 2025/26 will be used to determine an Indicative Activity Plan for 2026/27 and future contract years. Delivery date Providers should build on the existing delivery of vaccinations including HPV GBMSM and the accelerated Mpox vaccination programme (where implemented) and make arrangements to deliver to the eligible population accessing their services from August 2025. Providers should be offering both vaccines by no later than 01 September 2025. Provider Eligibility Criteria: Eligible providers must: * Hold a current Local Authority contract for the delivery of Sexual Health Services for one or more of the Lots/Localities as identified in this procurement process. * Pass all questions within the Regulation 20 questionnaire parts 1 and part 2 and the associated quality and financial stability assessment in part 3 of the questionnaire. Contract Term: To commence in August 2025 and providers should be offering both vaccines by no later than 01 September 2025. The contract term will be co-terminus with the Local Authority contract for Sexual Health Services as highlighted for each Location/Lot which includes any permissible extension periods which would be subject to the enactment of the Local Authority: Location/Lot: Yorkshire & Humber: * Lot 6 - Kirklees - service to commence by 01 September with an expiry 31 March 2032.
Options: The contract term will be co-terminus with the Local Authority contract for Sexual Health Services as highlighted for each Location/Lot which includes any permissible extension periods which would be subject to the enactment of the Local Authority: Lot 6 - Kirklees - service to commence by 01 September with an expiry 31 March 2032.
Lot 7 - WakefieldNHS England - North East and Yorkshire (the Relevant Authority) intends to award these contracts under the Direct Award Process B under the Health Care Services (Provider Selection Regime) regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to these awards. Following the government's acceptance of the Joint Committee on Vaccination and Immunisation (JCVI) advice that the NHS should implement: * a routine mpox pre-exposure vaccination programme building on the existing offer JCVI statement on mpox vaccination as a routine programme - GOV.UK * a routine opportunistic gonorrhoea vaccination programme JCVI advice on the use of meningococcal B vaccination for the prevention of gonorrhoea - GOV.UK The Relevant Authority is now seeking suitable providers by no later than 01 September 2025 necsu.psrprocurement@nhs.net to deliver the vaccinations alongside existing vaccination programmes (HPV GBMSM) delivered in place-based Local Authority commissioned sexual health services. Providers must deliver sexual health services in identified localities and work with partners to ensure effective programme coverage and equity of access to the local eligible population. Eligibility The JCVI advised that the vaccination programmes, which have similar eligibility criteria, should primarily target gay, bisexual and other men who have sex with men (GBMSM) who meet the eligibility criteria and are at highest risk of exposure to Mpox and Gonorrhoea. There may also be a small number of individuals other than GBMSM with a similar risk of infection as the eligible GBMSM groups who can be offered the vaccines. Individuals should be identified through sexual health services using markers of high risk of infection. This includes a recent history of multiple sexual partners or recent bacterial sexually transmitted infection. Full details on the eligible cohorts for each programme are available in the service specifications for each programme. Activity/funding Funding of PS10.06 will be provided for each dose of vaccine delivered to members of the identified cohort. An additional PS8.00 per vaccination delivered will be provided in 2025/26 to support mobilisation. This additional implementation payment will be reviewed in advance of 2026/27 contract year. As these are newly developed programmes, no baseline activity level for these vaccinations is available. Activity delivered in 2025/26 will be used to determine an Indicative Activity Plan for 2026/27 and future contract years. Delivery date Providers should build on the existing delivery of vaccinations including HPV GBMSM and the accelerated Mpox vaccination programme (where implemented) and make arrangements to deliver to the eligible population accessing their services from August 2025. Providers should be offering both vaccines by no later than 01 September 2025. Provider Eligibility Criteria: Eligible providers must: * Hold a current Local Authority contract for the delivery of Sexual Health Services for one or more of the Lots/Localities as identified in this procurement process. * Pass all questions within the Regulation 20 questionnaire parts 1 and part 2 and the associated quality and financial stability assessment in part 3 of the questionnaire. Contract Term: To commence in August 2025 and providers should be offering both vaccines by no later than 01 September 2025. The contract term will be co-terminus with the Local Authority contract for Sexual Health Services as highlighted for each Location/Lot which includes any permissible extension periods which would be subject to the enactment of the Local Authority: Location/Lot: Yorkshire & Humber: * Lot 7 - Wakefield - service to commence by 01 September with an expiry 30 September 2031.
Options: The contract term will be co-terminus with the Local Authority contract for Sexual Health Services as highlighted for each Location/Lot which includes any permissible extension periods which would be subject to the enactment of the Local Authority: Lot 7 - Wakefield - service to commence by 01 September with an expiry 30 September 2031.
Lot 8 - BarnsleyNHS England - North East and Yorkshire (the Relevant Authority) intends to award these contracts under the Direct Award Process B under the Health Care Services (Provider Selection Regime) regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to these awards. Following the government's acceptance of the Joint Committee on Vaccination and Immunisation (JCVI) advice that the NHS should implement: * a routine mpox pre-exposure vaccination programme building on the existing offer JCVI statement on mpox vaccination as a routine programme - GOV.UK * a routine opportunistic gonorrhoea vaccination programme JCVI advice on the use of meningococcal B vaccination for the prevention of gonorrhoea - GOV.UK The Relevant Authority is now seeking suitable providers by no later than 01 September 2025 necsu.psrprocurement@nhs.net to deliver the vaccinations alongside existing vaccination programmes (HPV GBMSM) delivered in place-based Local Authority commissioned sexual health services. Providers must deliver sexual health services in identified localities and work with partners to ensure effective programme coverage and equity of access to the local eligible population. Eligibility The JCVI advised that the vaccination programmes, which have similar eligibility criteria, should primarily target gay, bisexual and other men who have sex with men (GBMSM) who meet the eligibility criteria and are at highest risk of exposure to Mpox and Gonorrhoea. There may also be a small number of individuals other than GBMSM with a similar risk of infection as the eligible GBMSM groups who can be offered the vaccines. Individuals should be identified through sexual health services using markers of high risk of infection. This includes a recent history of multiple sexual partners or recent bacterial sexually transmitted infection. Full details on the eligible cohorts for each programme are available in the service specifications for each programme. Activity/funding Funding of PS10.06 will be provided for each dose of vaccine delivered to members of the identified cohort. An additional PS8.00 per vaccination delivered will be provided in 2025/26 to support mobilisation. This additional implementation payment will be reviewed in advance of 2026/27 contract year. As these are newly developed programmes, no baseline activity level for these vaccinations is available. Activity delivered in 2025/26 will be used to determine an Indicative Activity Plan for 2026/27 and future contract years. Delivery date Providers should build on the existing delivery of vaccinations including HPV GBMSM and the accelerated Mpox vaccination programme (where implemented) and make arrangements to deliver to the eligible population accessing their services from August 2025. Providers should be offering both vaccines by no later than 01 September 2025. Provider Eligibility Criteria: Eligible providers must: * Hold a current Local Authority contract for the delivery of Sexual Health Services for one or more of the Lots/Localities as identified in this procurement process. * Pass all questions within the Regulation 20 questionnaire parts 1 and part 2 and the associated quality and financial stability assessment in part 3 of the questionnaire. Contract Term: To commence in August 2025 and providers should be offering both vaccines by no later than 01 September 2025. The contract term will be co-terminus with the Local Authority contract for Sexual Health Services as highlighted for each Location/Lot which includes any permissible extension periods which would be subject to the enactment of the Local Authority: Location/Lot: Yorkshire & Humber: * Lot 8 - Barnsley - service to commence by 01 September with an expiry 30 June 2028.
Options: The contract term will be co-terminus with the Local Authority contract for Sexual Health Services as highlighted for each Location/Lot which includes any permissible extension periods which would be subject to the enactment of the Local Authority: Lot 8 - Barnsley - service to commence by 01 September with an expiry 30 June 2028.
Lot 9 - DoncasterNHS England - North East and Yorkshire (the Relevant Authority) intends to award these contracts under the Direct Award Process B under the Health Care Services (Provider Selection Regime) regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to these awards. Following the government's acceptance of the Joint Committee on Vaccination and Immunisation (JCVI) advice that the NHS should implement: * a routine mpox pre-exposure vaccination programme building on the existing offer JCVI statement on mpox vaccination as a routine programme - GOV.UK * a routine opportunistic gonorrhoea vaccination programme JCVI advice on the use of meningococcal B vaccination for the prevention of gonorrhoea - GOV.UK The Relevant Authority is now seeking suitable providers by no later than 01 September 2025 necsu.psrprocurement@nhs.net to deliver the vaccinations alongside existing vaccination programmes (HPV GBMSM) delivered in place-based Local Authority commissioned sexual health services. Providers must deliver sexual health services in identified localities and work with partners to ensure effective programme coverage and equity of access to the local eligible population. Eligibility The JCVI advised that the vaccination programmes, which have similar eligibility criteria, should primarily target gay, bisexual and other men who have sex with men (GBMSM) who meet the eligibility criteria and are at highest risk of exposure to Mpox and Gonorrhoea. There may also be a small number of individuals other than GBMSM with a similar risk of infection as the eligible GBMSM groups who can be offered the vaccines. Individuals should be identified through sexual health services using markers of high risk of infection. This includes a recent history of multiple sexual partners or recent bacterial sexually transmitted infection. Full details on the eligible cohorts for each programme are available in the service specifications for each programme. Activity/funding Funding of PS10.06 will be provided for each dose of vaccine delivered to members of the identified cohort. An additional PS8.00 per vaccination delivered will be provided in 2025/26 to support mobilisation. This additional implementation payment will be reviewed in advance of 2026/27 contract year. As these are newly developed programmes, no baseline activity level for these vaccinations is available. Activity delivered in 2025/26 will be used to determine an Indicative Activity Plan for 2026/27 and future contract years. Delivery date Providers should build on the existing delivery of vaccinations including HPV GBMSM and the accelerated Mpox vaccination programme (where implemented) and make arrangements to deliver to the eligible population accessing their services from August 2025. Providers should be offering both vaccines by no later than 01 September 2025. Provider Eligibility Criteria: Eligible providers must: * Hold a current Local Authority contract for the delivery of Sexual Health Services for one or more of the Lots/Localities as identified in this procurement process. * Pass all questions within the Regulation 20 questionnaire parts 1 and part 2 and the associated quality and financial stability assessment in part 3 of the questionnaire. Contract Term: To commence in August 2025 and providers should be offering both vaccines by no later than 01 September 2025. The contract term will be co-terminus with the Local Authority contract for Sexual Health Services as highlighted for each Location/Lot which includes any permissible extension periods which would be subject to the enactment of the Local Authority: Location/Lot: Yorkshire & Humber: * Lot 9 - Doncaster - service to commence by 01 September with an expiry 30 September 2027.
Options: The contract term will be co-terminus with the Local Authority contract for Sexual Health Services as highlighted for each Location/Lot which includes any permissible extension periods which would be subject to the enactment of the Local Authority: Lot 9 - Doncaster - service to commence by 01 September with an expiry 30 September 2027.
Lot 10 - Newcastle Upon TyneNHS England - North East and Yorkshire (the Relevant Authority) intends to award these contracts under the Direct Award Process B under the Health Care Services (Provider Selection Regime) regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to these awards. Following the government's acceptance of the Joint Committee on Vaccination and Immunisation (JCVI) advice that the NHS should implement: * a routine mpox pre-exposure vaccination programme building on the existing offer JCVI statement on mpox vaccination as a routine programme - GOV.UK * a routine opportunistic gonorrhoea vaccination programme JCVI advice on the use of meningococcal B vaccination for the prevention of gonorrhoea - GOV.UK The Relevant Authority is now seeking suitable providers by no later than 01 September 2025 necsu.psrprocurement@nhs.net to deliver the vaccinations alongside existing vaccination programmes (HPV GBMSM) delivered in place-based Local Authority commissioned sexual health services. Providers must deliver sexual health services in identified localities and work with partners to ensure effective programme coverage and equity of access to the local eligible population. Eligibility The JCVI advised that the vaccination programmes, which have similar eligibility criteria, should primarily target gay, bisexual and other men who have sex with men (GBMSM) who meet the eligibility criteria and are at highest risk of exposure to Mpox and Gonorrhoea. There may also be a small number of individuals other than GBMSM with a similar risk of infection as the eligible GBMSM groups who can be offered the vaccines. Individuals should be identified through sexual health services using markers of high risk of infection. This includes a recent history of multiple sexual partners or recent bacterial sexually transmitted infection. Full details on the eligible cohorts for each programme are available in the service specifications for each programme. Activity/funding Funding of PS10.06 will be provided for each dose of vaccine delivered to members of the identified cohort. An additional PS8.00 per vaccination delivered will be provided in 2025/26 to support mobilisation. This additional implementation payment will be reviewed in advance of 2026/27 contract year. As these are newly developed programmes, no baseline activity level for these vaccinations is available. Activity delivered in 2025/26 will be used to determine an Indicative Activity Plan for 2026/27 and future contract years. Delivery date Providers should build on the existing delivery of vaccinations including HPV GBMSM and the accelerated Mpox vaccination programme (where implemented) and make arrangements to deliver to the eligible population accessing their services from August 2025. Providers should be offering both vaccines by no later than 01 September 2025. Provider Eligibility Criteria: Eligible providers must: * Hold a current Local Authority contract for the delivery of Sexual Health Services for one or more of the Lots/Localities as identified in this procurement process. * Pass all questions within the Regulation 20 questionnaire parts 1 and part 2 and the associated quality and financial stability assessment in part 3 of the questionnaire. Contract Term: To commence in August 2025 and providers should be offering both vaccines by no later than 01 September 2025. The contract term will be co-terminus with the Local Authority contract for Sexual Health Services as highlighted for each Location/Lot which includes any permissible extension periods which would be subject to the enactment of the Local Authority: Location/Lot: North East and North Cumbria: * Lot 10 - Newcastle Upon Tyne - service to commence by 01 September expiry 30 September 2030.
Options: The contract term will be co-terminus with the Local Authority contract for Sexual Health Services as highlighted for each Location/Lot which includes any permissible extension periods which would be subject to the enactment of the Local Authority: Lot 10 - Newcastle Upon Tyne - service to commence by 01 September expiry 30 September 2030.
Procurement Information
The Relevant Authority intends to award this contract under the Direct Award Process B under the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award. There were no Conflicts of Interest.
Notice Details
Publication & Lifecycle
- Open Contracting ID
- ocds-h6vhtk-0590ce
- Publication Source
- Find A Tender Service
- Latest Notice
- https://www.find-tender.service.gov.uk/Notice/052590-2025
- Current Stage
- Award
- All Stages
- Award
Procurement Classification
- Notice Type
- Award Notice
- Procurement Type
- Standard
- Procurement Category
- Services
- Procurement Method
- Limited
- Procurement Method Details
- Award procedure without prior publication of a call for competition
- Tender Suitability
- Not specified
- Awardee Scale
- Large
Common Procurement Vocabulary (CPV)
- CPV Divisions
85 - Health and social work services
-
- CPV Codes
85140000 - Miscellaneous health services
Notice Value(s)
- Tender Value
- Not specified
- Lots Value
- Not specified
- Awards Value
- Not specified
- Contracts Value
- Not specified
Notice Dates
- Publication Date
- 29 Aug 20255 months ago
- Submission Deadline
- Not specified
- Future Notice Date
- Not specified
- Award Date
- 19 Aug 20256 months ago
- Contract Period
- Not specified - Not specified
- Recurrence
- Not specified
Notice Status
- Tender Status
- Complete
- Lots Status
- Cancelled
- Awards Status
- Active
- Contracts Status
- Active
Buyer & Supplier
Contracting Authority (Buyer)
- Main Buyer
- NHS ENGLAND NORTH EAST AND YORKSHIRE
- Contact Name
- Not specified
- Contact Email
- necsu.psrprocurement@nhs.net
- Contact Phone
- Not specified
Buyer Location
- Locality
- LEEDS
- Postcode
- LS11 5BD
- Post Town
- Leeds
- Country
- England
-
- Major Region (ITL 1)
- TLE Yorkshire and The Humber
- Basic Region (ITL 2)
- TLE4 West Yorkshire
- Small Region (ITL 3)
- TLE42 Leeds
- Delivery Location
- TLC22 Tyneside, TLE11 Kingston upon Hull, City of, TLE12 East Riding of Yorkshire, TLE13 North and North East Lincolnshire, TLE31 Barnsley, Doncaster and Rotherham, TLE4 West Yorkshire, TLE41 Bradford, TLE42 Leeds, TLE45 Wakefield
-
- Local Authority
- Leeds
- Electoral Ward
- Hunslet & Riverside
- Westminster Constituency
- Leeds South
Further Information
Notice URLs
Open Contracting Data Standard (OCDS)
View full OCDS Record for this contracting process
The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.
{
"tag": [
"compiled"
],
"id": "ocds-h6vhtk-0590ce-2025-08-29T16:21:16+01:00",
"date": "2025-08-29T16:21:16+01:00",
"ocid": "ocds-h6vhtk-0590ce",
"description": "The Relevant Authority intends to award these contracts under the Direct Award Process B under the Health Care Services (Provider Selection Regime) Regulations 2023. All new services - All existing providers. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to these awards. Details of individual making decisions: Deputy Head of Public Health, Yorkshire and the Humber, NHS England (North East and Yorkshire). Senior Commissioning Manager - North East and North Cumbria, NHS England (North East and Yorkshire). Screening and Immunisation Place Lead North Lincolnshire and North East Lincolnshire Y&H Public Health Programmes Team NHS England (North East & Yorkshire). Finance Manager - Direct Commissioning (HJ & PH), NHS England Regional Team - North East & Yorkshire. North East and North Cumbria Public Health Commissioning Management Group. There were no conflicts of Interest.",
"initiationType": "tender",
"tender": {
"id": "NHSE1088",
"legalBasis": {
"id": "32014L0024",
"scheme": "CELEX"
},
"title": "NHSE1088 - Mpox Vaccination and Gonorrhoea Vaccination",
"status": "complete",
"classification": {
"scheme": "CPV",
"id": "85140000",
"description": "Miscellaneous health services"
},
"mainProcurementCategory": "services",
"description": "NHS England - North East and Yorkshire (the Relevant Authority) intends to award these contracts under the Direct Award Process B under the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to these awards. Following the government's acceptance of the Joint Committee on Vaccination and Immunisation (JCVI) advice that the NHS should implement: * a routine mpox pre-exposure vaccination programme building on the existing offer JCVI statement on mpox vaccination as a routine programme - GOV.UK * a routine opportunistic gonorrhoea vaccination programme JCVI advice on the use of meningococcal B vaccination for the prevention of gonorrhoea - GOV.UK The Relevant Authority is now seeking suitable providers by no later than 01 September 2025 necsu.psrprocurement@nhs.net to deliver the vaccinations alongside existing vaccination programmes (HPV GBMSM) delivered in place-based Local Authority commissioned sexual health services. Providers must deliver sexual health services in identified localities and work with partners to ensure effective programme coverage and equity of access to the local eligible population. The JCVI advised that the vaccination programmes, which have similar eligibility criteria, should primarily target gay, bisexual and other men who have sex with men (GBMSM) who meet the eligibility criteria and are at highest risk of exposure to Mpox and Gonorrhoea. There may also be a small number of individuals other than GBMSM with a similar risk of infection as the eligible GBMSM groups who can be offered the vaccines. Individuals should be identified through sexual health services using markers of high risk of infection. This includes a recent history of multiple sexual partners or recent bacterial sexually transmitted infection. Full details on the eligible cohorts for each programme are available in the service specifications for each programme. Funding of PS10.06 will be provided for each dose of vaccine delivered to members of the identified cohort. An additional PS8.00 per vaccination delivered will be provided in 2025/26 to support mobilisation. This additional implementation payment will be reviewed in advance of 2026/27 contract year. As these are newly developed programmes, no baseline activity level for these vaccinations is available. Activity delivered in 2025/26 will be used to determine an Indicative Activity Plan for 2026/27 and future contract years. Providers should build on the existing delivery of vaccinations including HPV GBMSM and the accelerated Mpox vaccination programme (where implemented) and make arrangements to deliver to the eligible population accessing their services from August 2025. Providers should be offering both vaccines by no later than 01 September 2025. Eligible providers must: * Hold a current Local Authority contract for the delivery of Sexual Health Services for one or more of the Lots/Localities as identified in this procurement process. * Pass all questions within the Regulation 20 questionnaire parts 1 and part 2 and the associated quality and financial stability assessment in part 3 of the questionnaire. To commence in August 2025 and providers should be offering both vaccines by no later than 01 September 2025. The contract term will be co-terminus with the Local Authority contract for Sexual Health Services as highlighted for each Location/Lot which includes any permissible extension periods which would be subject to the enactment of the Local Authority: Locations/Lots: Yorkshire & Humber: * Lot 1 - North Lincolnshire and North East Lincolnshire * Lot 2 - Hull * Lot 3 - East Riding * Lot 4 - Leeds * Lot 5 - Bradford * Lot 6 - Kirklees * Lot 7 - Wakefield * Lot 8 - Barnsley * Lot 9 - Doncaster North East and North Cumbria: * Lot 10 - Newcastle Upon Tyne",
"lots": [
{
"id": "1",
"title": "Lot 1 - North Lincolnshire and North East Lincolnshire",
"description": "NHS England - North East and Yorkshire (the Relevant Authority) intends to award these contracts under the Direct Award Process B under the Health Care Services (Provider Selection Regime) regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to these awards. Following the government's acceptance of the Joint Committee on Vaccination and Immunisation (JCVI) advice that the NHS should implement: * a routine mpox pre-exposure vaccination programme building on the existing offer JCVI statement on mpox vaccination as a routine programme - GOV.UK * a routine opportunistic gonorrhoea vaccination programme JCVI advice on the use of meningococcal B vaccination for the prevention of gonorrhoea - GOV.UK The Relevant Authority is now seeking suitable providers by no later than 01 September 2025 necsu.psrprocurement@nhs.net to deliver the vaccinations alongside existing vaccination programmes (HPV GBMSM) delivered in place-based Local Authority commissioned sexual health services. Providers must deliver sexual health services in identified localities and work with partners to ensure effective programme coverage and equity of access to the local eligible population. Eligibility The JCVI advised that the vaccination programmes, which have similar eligibility criteria, should primarily target gay, bisexual and other men who have sex with men (GBMSM) who meet the eligibility criteria and are at highest risk of exposure to Mpox and Gonorrhoea. There may also be a small number of individuals other than GBMSM with a similar risk of infection as the eligible GBMSM groups who can be offered the vaccines. Individuals should be identified through sexual health services using markers of high risk of infection. This includes a recent history of multiple sexual partners or recent bacterial sexually transmitted infection. Full details on the eligible cohorts for each programme are available in the service specifications for each programme. Activity/funding Funding of PS10.06 will be provided for each dose of vaccine delivered to members of the identified cohort. An additional PS8.00 per vaccination delivered will be provided in 2025/26 to support mobilisation. This additional implementation payment will be reviewed in advance of 2026/27 contract year. As these are newly developed programmes, no baseline activity level for these vaccinations is available. Activity delivered in 2025/26 will be used to determine an Indicative Activity Plan for 2026/27 and future contract years. Delivery date Providers should build on the existing delivery of vaccinations including HPV GBMSM and the accelerated Mpox vaccination programme (where implemented) and make arrangements to deliver to the eligible population accessing their services from August 2025. Providers should be offering both vaccines by no later than 01 September 2025. Provider Eligibility Criteria: Eligible providers must: * Hold a current Local Authority contract for the delivery of Sexual Health Services for one or more of the Lots/Localities as identified in this procurement process. * Pass all questions within the Regulation 20 questionnaire parts 1 and part 2 and the associated quality and financial stability assessment in part 3 of the questionnaire. Contract Term: To commence in August 2025 and providers should be offering both vaccines by no later than 01 September 2025. The contract term will be co-terminus with the Local Authority contract for Sexual Health Services as highlighted for each Location/Lot which includes any permissible extension periods which would be subject to the enactment of the Local Authority: Location/Lot: Yorkshire & Humber: * Lot 1 - North Lincolnshire and North East Lincolnshire - service to commence by 01 September with an expiry 31 March 2029 - with option to extend for 2-years (1+1).",
"awardCriteria": {
"criteria": [
{
"name": "Patient Choice",
"type": "quality",
"description": "100"
},
{
"name": "Patient Choice",
"type": "cost",
"description": "100"
}
]
},
"hasOptions": true,
"options": {
"description": "The contract term will be co-terminus with the Local Authority contract for Sexual Health Services as highlighted for each Location/Lot which includes any permissible extension periods which would be subject to the enactment of the Local Authority: Lot 1 - North Lincolnshire and North East Lincolnshire - service to commence by 01 September with an expiry 31 March 2029 - with option to extend for 2-years (1+1)."
},
"status": "cancelled"
},
{
"id": "2",
"title": "Lot 2 - Hull",
"description": "NHS England - North East and Yorkshire (the Relevant Authority) intends to award these contracts under the Direct Award Process B under the Health Care Services (Provider Selection Regime) regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to these awards. Following the government's acceptance of the Joint Committee on Vaccination and Immunisation (JCVI) advice that the NHS should implement: * a routine mpox pre-exposure vaccination programme building on the existing offer JCVI statement on mpox vaccination as a routine programme - GOV.UK * a routine opportunistic gonorrhoea vaccination programme JCVI advice on the use of meningococcal B vaccination for the prevention of gonorrhoea - GOV.UK The Relevant Authority is now seeking suitable providers by no later than 01 September 2025 necsu.psrprocurement@nhs.net to deliver the vaccinations alongside existing vaccination programmes (HPV GBMSM) delivered in place-based Local Authority commissioned sexual health services. Providers must deliver sexual health services in identified localities and work with partners to ensure effective programme coverage and equity of access to the local eligible population. Eligibility The JCVI advised that the vaccination programmes, which have similar eligibility criteria, should primarily target gay, bisexual and other men who have sex with men (GBMSM) who meet the eligibility criteria and are at highest risk of exposure to Mpox and Gonorrhoea. There may also be a small number of individuals other than GBMSM with a similar risk of infection as the eligible GBMSM groups who can be offered the vaccines. Individuals should be identified through sexual health services using markers of high risk of infection. This includes a recent history of multiple sexual partners or recent bacterial sexually transmitted infection. Full details on the eligible cohorts for each programme are available in the service specifications for each programme. Activity/funding Funding of PS10.06 will be provided for each dose of vaccine delivered to members of the identified cohort. An additional PS8.00 per vaccination delivered will be provided in 2025/26 to support mobilisation. This additional implementation payment will be reviewed in advance of 2026/27 contract year. As these are newly developed programmes, no baseline activity level for these vaccinations is available. Activity delivered in 2025/26 will be used to determine an Indicative Activity Plan for 2026/27 and future contract years. Delivery date Providers should build on the existing delivery of vaccinations including HPV GBMSM and the accelerated Mpox vaccination programme (where implemented) and make arrangements to deliver to the eligible population accessing their services from August 2025. Providers should be offering both vaccines by no later than 01 September 2025. Provider Eligibility Criteria: Eligible providers must: * Hold a current Local Authority contract for the delivery of Sexual Health Services for one or more of the Lots/Localities as identified in this procurement process. * Pass all questions within the Regulation 20 questionnaire parts 1 and part 2 and the associated quality and financial stability assessment in part 3 of the questionnaire. Contract Term: To commence in August 2025 and providers should be offering both vaccines by no later than 01 September 2025. The contract term will be co-terminus with the Local Authority contract for Sexual Health Services as highlighted for each Location/Lot which includes any permissible extension periods which would be subject to the enactment of the Local Authority: Location/Lot: Yorkshire & Humber: * Lot 2 - Hull - service to commence by 01 September with an expiry 01 April 2026 with option to extend for 6-years (4+2).",
"awardCriteria": {
"criteria": [
{
"name": "Patient Choice",
"type": "quality",
"description": "100"
},
{
"name": "Patient Choice",
"type": "cost",
"description": "100"
}
]
},
"hasOptions": true,
"options": {
"description": "The contract term will be co-terminus with the Local Authority contract for Sexual Health Services as highlighted for each Location/Lot which includes any permissible extension periods which would be subject to the enactment of the Local Authority: * Lot 2 - Hull - service to commence by 01 September with an expiry 01 April 2026 with option to extend for 6-years (4+2)."
},
"status": "cancelled"
},
{
"id": "3",
"title": "Lot 3 - East Riding",
"description": "NHS England - North East and Yorkshire (the Relevant Authority) intends to award these contracts under the Direct Award Process B under the Health Care Services (Provider Selection Regime) regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to these awards. Following the government's acceptance of the Joint Committee on Vaccination and Immunisation (JCVI) advice that the NHS should implement: * a routine mpox pre-exposure vaccination programme building on the existing offer JCVI statement on mpox vaccination as a routine programme - GOV.UK * a routine opportunistic gonorrhoea vaccination programme JCVI advice on the use of meningococcal B vaccination for the prevention of gonorrhoea - GOV.UK The Relevant Authority is now seeking suitable providers by no later than 01 September 2025 necsu.psrprocurement@nhs.net to deliver the vaccinations alongside existing vaccination programmes (HPV GBMSM) delivered in place-based Local Authority commissioned sexual health services. Providers must deliver sexual health services in identified localities and work with partners to ensure effective programme coverage and equity of access to the local eligible population. Eligibility The JCVI advised that the vaccination programmes, which have similar eligibility criteria, should primarily target gay, bisexual and other men who have sex with men (GBMSM) who meet the eligibility criteria and are at highest risk of exposure to Mpox and Gonorrhoea. There may also be a small number of individuals other than GBMSM with a similar risk of infection as the eligible GBMSM groups who can be offered the vaccines. Individuals should be identified through sexual health services using markers of high risk of infection. This includes a recent history of multiple sexual partners or recent bacterial sexually transmitted infection. Full details on the eligible cohorts for each programme are available in the service specifications for each programme. Activity/funding Funding of PS10.06 will be provided for each dose of vaccine delivered to members of the identified cohort. An additional PS8.00 per vaccination delivered will be provided in 2025/26 to support mobilisation. This additional implementation payment will be reviewed in advance of 2026/27 contract year. As these are newly developed programmes, no baseline activity level for these vaccinations is available. Activity delivered in 2025/26 will be used to determine an Indicative Activity Plan for 2026/27 and future contract years. Delivery date Providers should build on the existing delivery of vaccinations including HPV GBMSM and the accelerated Mpox vaccination programme (where implemented) and make arrangements to deliver to the eligible population accessing their services from August 2025. Providers should be offering both vaccines by no later than 01 September 2025. Provider Eligibility Criteria: Eligible providers must: * Hold a current Local Authority contract for the delivery of Sexual Health Services for one or more of the Lots/Localities as identified in this procurement process. * Pass all questions within the Regulation 20 questionnaire parts 1 and part 2 and the associated quality and financial stability assessment in part 3 of the questionnaire. Contract Term: To commence in August 2025 and providers should be offering both vaccines by no later than 01 September 2025. The contract term will be co-terminus with the Local Authority contract for Sexual Health Services as highlighted for each Location/Lot which includes any permissible extension periods which would be subject to the enactment of the Local Authority: Location/Lot: Yorkshire & Humber: Lot 3 - East Riding - service to commence by 01 September with an expiry 31 March 2026.",
"awardCriteria": {
"criteria": [
{
"name": "Patient Choice",
"type": "quality",
"description": "100"
},
{
"name": "Patient Choice",
"type": "cost",
"description": "100"
}
]
},
"hasOptions": true,
"options": {
"description": "The contract term will be co-terminus with the Local Authority contract for Sexual Health Services as highlighted for each Location/Lot which includes any permissible extension periods which would be subject to the enactment of the Local Authority: Lot 3 - East Riding - service to commence by 01 September with an expiry 31 March 2026."
},
"status": "cancelled"
},
{
"id": "4",
"title": "Lot 4 - Leeds",
"description": "NHS England - North East and Yorkshire (the Relevant Authority) intends to award these contracts under the Direct Award Process B under the Health Care Services (Provider Selection Regime) regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to these awards. Following the government's acceptance of the Joint Committee on Vaccination and Immunisation (JCVI) advice that the NHS should implement: * a routine mpox pre-exposure vaccination programme building on the existing offer JCVI statement on mpox vaccination as a routine programme - GOV.UK * a routine opportunistic gonorrhoea vaccination programme JCVI advice on the use of meningococcal B vaccination for the prevention of gonorrhoea - GOV.UK The Relevant Authority is now seeking suitable providers by no later than 01 September 2025 necsu.psrprocurement@nhs.net to deliver the vaccinations alongside existing vaccination programmes (HPV GBMSM) delivered in place-based Local Authority commissioned sexual health services. Providers must deliver sexual health services in identified localities and work with partners to ensure effective programme coverage and equity of access to the local eligible population. Eligibility The JCVI advised that the vaccination programmes, which have similar eligibility criteria, should primarily target gay, bisexual and other men who have sex with men (GBMSM) who meet the eligibility criteria and are at highest risk of exposure to Mpox and Gonorrhoea. There may also be a small number of individuals other than GBMSM with a similar risk of infection as the eligible GBMSM groups who can be offered the vaccines. Individuals should be identified through sexual health services using markers of high risk of infection. This includes a recent history of multiple sexual partners or recent bacterial sexually transmitted infection. Full details on the eligible cohorts for each programme are available in the service specifications for each programme. Activity/funding Funding of PS10.06 will be provided for each dose of vaccine delivered to members of the identified cohort. An additional PS8.00 per vaccination delivered will be provided in 2025/26 to support mobilisation. This additional implementation payment will be reviewed in advance of 2026/27 contract year. As these are newly developed programmes, no baseline activity level for these vaccinations is available. Activity delivered in 2025/26 will be used to determine an Indicative Activity Plan for 2026/27 and future contract years. Delivery date Providers should build on the existing delivery of vaccinations including HPV GBMSM and the accelerated Mpox vaccination programme (where implemented) and make arrangements to deliver to the eligible population accessing their services from August 2025. Providers should be offering both vaccines by no later than 01 September 2025. Provider Eligibility Criteria: Eligible providers must: * Hold a current Local Authority contract for the delivery of Sexual Health Services for one or more of the Lots/Localities as identified in this procurement process. * Pass all questions within the Regulation 20 questionnaire parts 1 and part 2 and the associated quality and financial stability assessment in part 3 of the questionnaire. Contract Term: To commence in August 2025 and providers should be offering both vaccines by no later than 01 September 2025. The contract term will be co-terminus with the Local Authority contract for Sexual Health Services as highlighted for each Location/Lot which includes any permissible extension periods which would be subject to the enactment of the Local Authority: Location/Lot: Yorkshire & Humber: * Lot 4 - Leeds - service to commence by 01 September with an expiry 31 March 2030 with option to extend by 4-years.",
"awardCriteria": {
"criteria": [
{
"name": "Patient Choice",
"type": "quality",
"description": "100"
},
{
"name": "Patient Choice",
"type": "cost",
"description": "100"
}
]
},
"hasOptions": true,
"options": {
"description": "The contract term will be co-terminus with the Local Authority contract for Sexual Health Services as highlighted for each Location/Lot which includes any permissible extension periods which would be subject to the enactment of the Local Authority: Lot 4 - Leeds - service to commence by 01 September with an expiry 31 March 2030 with option to extend by 4-years."
},
"status": "cancelled"
},
{
"id": "5",
"title": "Lot 5 - Bradford",
"description": "NHS England - North East and Yorkshire (the Relevant Authority) intends to award these contracts under the Direct Award Process B under the Health Care Services (Provider Selection Regime) regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to these awards. Following the government's acceptance of the Joint Committee on Vaccination and Immunisation (JCVI) advice that the NHS should implement: * a routine mpox pre-exposure vaccination programme building on the existing offer JCVI statement on mpox vaccination as a routine programme - GOV.UK * a routine opportunistic gonorrhoea vaccination programme JCVI advice on the use of meningococcal B vaccination for the prevention of gonorrhoea - GOV.UK The Relevant Authority is now seeking suitable providers by no later than 01 September 2025 necsu.psrprocurement@nhs.net to deliver the vaccinations alongside existing vaccination programmes (HPV GBMSM) delivered in place-based Local Authority commissioned sexual health services. Providers must deliver sexual health services in identified localities and work with partners to ensure effective programme coverage and equity of access to the local eligible population. Eligibility The JCVI advised that the vaccination programmes, which have similar eligibility criteria, should primarily target gay, bisexual and other men who have sex with men (GBMSM) who meet the eligibility criteria and are at highest risk of exposure to Mpox and Gonorrhoea. There may also be a small number of individuals other than GBMSM with a similar risk of infection as the eligible GBMSM groups who can be offered the vaccines. Individuals should be identified through sexual health services using markers of high risk of infection. This includes a recent history of multiple sexual partners or recent bacterial sexually transmitted infection. Full details on the eligible cohorts for each programme are available in the service specifications for each programme. Activity/funding Funding of PS10.06 will be provided for each dose of vaccine delivered to members of the identified cohort. An additional PS8.00 per vaccination delivered will be provided in 2025/26 to support mobilisation. This additional implementation payment will be reviewed in advance of 2026/27 contract year. As these are newly developed programmes, no baseline activity level for these vaccinations is available. Activity delivered in 2025/26 will be used to determine an Indicative Activity Plan for 2026/27 and future contract years. Delivery date Providers should build on the existing delivery of vaccinations including HPV GBMSM and the accelerated Mpox vaccination programme (where implemented) and make arrangements to deliver to the eligible population accessing their services from August 2025. Providers should be offering both vaccines by no later than 01 September 2025. Provider Eligibility Criteria: Eligible providers must: * Hold a current Local Authority contract for the delivery of Sexual Health Services for one or more of the Lots/Localities as identified in this procurement process. * Pass all questions within the Regulation 20 questionnaire parts 1 and part 2 and the associated quality and financial stability assessment in part 3 of the questionnaire. Contract Term: To commence in August 2025 and providers should be offering both vaccines by no later than 01 September 2025. The contract term will be co-terminus with the Local Authority contract for Sexual Health Services as highlighted for each Location/Lot which includes any permissible extension periods which would be subject to the enactment of the Local Authority: Location/Lot: Yorkshire & Humber: * Lot 5 - Bradford - service to commence by 01 September with an expiry 31 March 2033.",
"awardCriteria": {
"criteria": [
{
"name": "Patient Choice",
"type": "quality",
"description": "100"
},
{
"name": "Patient Choice",
"type": "cost",
"description": "100"
}
]
},
"hasOptions": true,
"options": {
"description": "The contract term will be co-terminus with the Local Authority contract for Sexual Health Services as highlighted for each Location/Lot which includes any permissible extension periods which would be subject to the enactment of the Local Authority: Lot 5 - Bradford - service to commence by 01 September with an expiry 31 March 2033."
},
"status": "cancelled"
},
{
"id": "6",
"title": "Lot 6 - Kirklees",
"description": "NHS England - North East and Yorkshire (the Relevant Authority) intends to award these contracts under the Direct Award Process B under the Health Care Services (Provider Selection Regime) regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to these awards. Following the government's acceptance of the Joint Committee on Vaccination and Immunisation (JCVI) advice that the NHS should implement: * a routine mpox pre-exposure vaccination programme building on the existing offer JCVI statement on mpox vaccination as a routine programme - GOV.UK * a routine opportunistic gonorrhoea vaccination programme JCVI advice on the use of meningococcal B vaccination for the prevention of gonorrhoea - GOV.UK The Relevant Authority is now seeking suitable providers by no later than 01 September 2025 necsu.psrprocurement@nhs.net to deliver the vaccinations alongside existing vaccination programmes (HPV GBMSM) delivered in place-based Local Authority commissioned sexual health services. Providers must deliver sexual health services in identified localities and work with partners to ensure effective programme coverage and equity of access to the local eligible population. Eligibility The JCVI advised that the vaccination programmes, which have similar eligibility criteria, should primarily target gay, bisexual and other men who have sex with men (GBMSM) who meet the eligibility criteria and are at highest risk of exposure to Mpox and Gonorrhoea. There may also be a small number of individuals other than GBMSM with a similar risk of infection as the eligible GBMSM groups who can be offered the vaccines. Individuals should be identified through sexual health services using markers of high risk of infection. This includes a recent history of multiple sexual partners or recent bacterial sexually transmitted infection. Full details on the eligible cohorts for each programme are available in the service specifications for each programme. Activity/funding Funding of PS10.06 will be provided for each dose of vaccine delivered to members of the identified cohort. An additional PS8.00 per vaccination delivered will be provided in 2025/26 to support mobilisation. This additional implementation payment will be reviewed in advance of 2026/27 contract year. As these are newly developed programmes, no baseline activity level for these vaccinations is available. Activity delivered in 2025/26 will be used to determine an Indicative Activity Plan for 2026/27 and future contract years. Delivery date Providers should build on the existing delivery of vaccinations including HPV GBMSM and the accelerated Mpox vaccination programme (where implemented) and make arrangements to deliver to the eligible population accessing their services from August 2025. Providers should be offering both vaccines by no later than 01 September 2025. Provider Eligibility Criteria: Eligible providers must: * Hold a current Local Authority contract for the delivery of Sexual Health Services for one or more of the Lots/Localities as identified in this procurement process. * Pass all questions within the Regulation 20 questionnaire parts 1 and part 2 and the associated quality and financial stability assessment in part 3 of the questionnaire. Contract Term: To commence in August 2025 and providers should be offering both vaccines by no later than 01 September 2025. The contract term will be co-terminus with the Local Authority contract for Sexual Health Services as highlighted for each Location/Lot which includes any permissible extension periods which would be subject to the enactment of the Local Authority: Location/Lot: Yorkshire & Humber: * Lot 6 - Kirklees - service to commence by 01 September with an expiry 31 March 2032.",
"awardCriteria": {
"criteria": [
{
"name": "Patient Choice",
"type": "quality",
"description": "100"
},
{
"name": "Patient Choice",
"type": "cost",
"description": "100"
}
]
},
"hasOptions": true,
"options": {
"description": "The contract term will be co-terminus with the Local Authority contract for Sexual Health Services as highlighted for each Location/Lot which includes any permissible extension periods which would be subject to the enactment of the Local Authority: Lot 6 - Kirklees - service to commence by 01 September with an expiry 31 March 2032."
},
"status": "cancelled"
},
{
"id": "7",
"title": "Lot 7 - Wakefield",
"description": "NHS England - North East and Yorkshire (the Relevant Authority) intends to award these contracts under the Direct Award Process B under the Health Care Services (Provider Selection Regime) regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to these awards. Following the government's acceptance of the Joint Committee on Vaccination and Immunisation (JCVI) advice that the NHS should implement: * a routine mpox pre-exposure vaccination programme building on the existing offer JCVI statement on mpox vaccination as a routine programme - GOV.UK * a routine opportunistic gonorrhoea vaccination programme JCVI advice on the use of meningococcal B vaccination for the prevention of gonorrhoea - GOV.UK The Relevant Authority is now seeking suitable providers by no later than 01 September 2025 necsu.psrprocurement@nhs.net to deliver the vaccinations alongside existing vaccination programmes (HPV GBMSM) delivered in place-based Local Authority commissioned sexual health services. Providers must deliver sexual health services in identified localities and work with partners to ensure effective programme coverage and equity of access to the local eligible population. Eligibility The JCVI advised that the vaccination programmes, which have similar eligibility criteria, should primarily target gay, bisexual and other men who have sex with men (GBMSM) who meet the eligibility criteria and are at highest risk of exposure to Mpox and Gonorrhoea. There may also be a small number of individuals other than GBMSM with a similar risk of infection as the eligible GBMSM groups who can be offered the vaccines. Individuals should be identified through sexual health services using markers of high risk of infection. This includes a recent history of multiple sexual partners or recent bacterial sexually transmitted infection. Full details on the eligible cohorts for each programme are available in the service specifications for each programme. Activity/funding Funding of PS10.06 will be provided for each dose of vaccine delivered to members of the identified cohort. An additional PS8.00 per vaccination delivered will be provided in 2025/26 to support mobilisation. This additional implementation payment will be reviewed in advance of 2026/27 contract year. As these are newly developed programmes, no baseline activity level for these vaccinations is available. Activity delivered in 2025/26 will be used to determine an Indicative Activity Plan for 2026/27 and future contract years. Delivery date Providers should build on the existing delivery of vaccinations including HPV GBMSM and the accelerated Mpox vaccination programme (where implemented) and make arrangements to deliver to the eligible population accessing their services from August 2025. Providers should be offering both vaccines by no later than 01 September 2025. Provider Eligibility Criteria: Eligible providers must: * Hold a current Local Authority contract for the delivery of Sexual Health Services for one or more of the Lots/Localities as identified in this procurement process. * Pass all questions within the Regulation 20 questionnaire parts 1 and part 2 and the associated quality and financial stability assessment in part 3 of the questionnaire. Contract Term: To commence in August 2025 and providers should be offering both vaccines by no later than 01 September 2025. The contract term will be co-terminus with the Local Authority contract for Sexual Health Services as highlighted for each Location/Lot which includes any permissible extension periods which would be subject to the enactment of the Local Authority: Location/Lot: Yorkshire & Humber: * Lot 7 - Wakefield - service to commence by 01 September with an expiry 30 September 2031.",
"awardCriteria": {
"criteria": [
{
"name": "Patient Choice",
"type": "quality",
"description": "100"
},
{
"name": "Patient Choice",
"type": "cost",
"description": "100"
}
]
},
"hasOptions": true,
"options": {
"description": "The contract term will be co-terminus with the Local Authority contract for Sexual Health Services as highlighted for each Location/Lot which includes any permissible extension periods which would be subject to the enactment of the Local Authority: Lot 7 - Wakefield - service to commence by 01 September with an expiry 30 September 2031."
},
"status": "cancelled"
},
{
"id": "8",
"title": "Lot 8 - Barnsley",
"description": "NHS England - North East and Yorkshire (the Relevant Authority) intends to award these contracts under the Direct Award Process B under the Health Care Services (Provider Selection Regime) regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to these awards. Following the government's acceptance of the Joint Committee on Vaccination and Immunisation (JCVI) advice that the NHS should implement: * a routine mpox pre-exposure vaccination programme building on the existing offer JCVI statement on mpox vaccination as a routine programme - GOV.UK * a routine opportunistic gonorrhoea vaccination programme JCVI advice on the use of meningococcal B vaccination for the prevention of gonorrhoea - GOV.UK The Relevant Authority is now seeking suitable providers by no later than 01 September 2025 necsu.psrprocurement@nhs.net to deliver the vaccinations alongside existing vaccination programmes (HPV GBMSM) delivered in place-based Local Authority commissioned sexual health services. Providers must deliver sexual health services in identified localities and work with partners to ensure effective programme coverage and equity of access to the local eligible population. Eligibility The JCVI advised that the vaccination programmes, which have similar eligibility criteria, should primarily target gay, bisexual and other men who have sex with men (GBMSM) who meet the eligibility criteria and are at highest risk of exposure to Mpox and Gonorrhoea. There may also be a small number of individuals other than GBMSM with a similar risk of infection as the eligible GBMSM groups who can be offered the vaccines. Individuals should be identified through sexual health services using markers of high risk of infection. This includes a recent history of multiple sexual partners or recent bacterial sexually transmitted infection. Full details on the eligible cohorts for each programme are available in the service specifications for each programme. Activity/funding Funding of PS10.06 will be provided for each dose of vaccine delivered to members of the identified cohort. An additional PS8.00 per vaccination delivered will be provided in 2025/26 to support mobilisation. This additional implementation payment will be reviewed in advance of 2026/27 contract year. As these are newly developed programmes, no baseline activity level for these vaccinations is available. Activity delivered in 2025/26 will be used to determine an Indicative Activity Plan for 2026/27 and future contract years. Delivery date Providers should build on the existing delivery of vaccinations including HPV GBMSM and the accelerated Mpox vaccination programme (where implemented) and make arrangements to deliver to the eligible population accessing their services from August 2025. Providers should be offering both vaccines by no later than 01 September 2025. Provider Eligibility Criteria: Eligible providers must: * Hold a current Local Authority contract for the delivery of Sexual Health Services for one or more of the Lots/Localities as identified in this procurement process. * Pass all questions within the Regulation 20 questionnaire parts 1 and part 2 and the associated quality and financial stability assessment in part 3 of the questionnaire. Contract Term: To commence in August 2025 and providers should be offering both vaccines by no later than 01 September 2025. The contract term will be co-terminus with the Local Authority contract for Sexual Health Services as highlighted for each Location/Lot which includes any permissible extension periods which would be subject to the enactment of the Local Authority: Location/Lot: Yorkshire & Humber: * Lot 8 - Barnsley - service to commence by 01 September with an expiry 30 June 2028.",
"awardCriteria": {
"criteria": [
{
"name": "Patient Choice",
"type": "quality",
"description": "100"
},
{
"name": "Patient Choice",
"type": "cost",
"description": "100"
}
]
},
"hasOptions": true,
"options": {
"description": "The contract term will be co-terminus with the Local Authority contract for Sexual Health Services as highlighted for each Location/Lot which includes any permissible extension periods which would be subject to the enactment of the Local Authority: Lot 8 - Barnsley - service to commence by 01 September with an expiry 30 June 2028."
},
"status": "cancelled"
},
{
"id": "9",
"title": "Lot 9 - Doncaster",
"description": "NHS England - North East and Yorkshire (the Relevant Authority) intends to award these contracts under the Direct Award Process B under the Health Care Services (Provider Selection Regime) regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to these awards. Following the government's acceptance of the Joint Committee on Vaccination and Immunisation (JCVI) advice that the NHS should implement: * a routine mpox pre-exposure vaccination programme building on the existing offer JCVI statement on mpox vaccination as a routine programme - GOV.UK * a routine opportunistic gonorrhoea vaccination programme JCVI advice on the use of meningococcal B vaccination for the prevention of gonorrhoea - GOV.UK The Relevant Authority is now seeking suitable providers by no later than 01 September 2025 necsu.psrprocurement@nhs.net to deliver the vaccinations alongside existing vaccination programmes (HPV GBMSM) delivered in place-based Local Authority commissioned sexual health services. Providers must deliver sexual health services in identified localities and work with partners to ensure effective programme coverage and equity of access to the local eligible population. Eligibility The JCVI advised that the vaccination programmes, which have similar eligibility criteria, should primarily target gay, bisexual and other men who have sex with men (GBMSM) who meet the eligibility criteria and are at highest risk of exposure to Mpox and Gonorrhoea. There may also be a small number of individuals other than GBMSM with a similar risk of infection as the eligible GBMSM groups who can be offered the vaccines. Individuals should be identified through sexual health services using markers of high risk of infection. This includes a recent history of multiple sexual partners or recent bacterial sexually transmitted infection. Full details on the eligible cohorts for each programme are available in the service specifications for each programme. Activity/funding Funding of PS10.06 will be provided for each dose of vaccine delivered to members of the identified cohort. An additional PS8.00 per vaccination delivered will be provided in 2025/26 to support mobilisation. This additional implementation payment will be reviewed in advance of 2026/27 contract year. As these are newly developed programmes, no baseline activity level for these vaccinations is available. Activity delivered in 2025/26 will be used to determine an Indicative Activity Plan for 2026/27 and future contract years. Delivery date Providers should build on the existing delivery of vaccinations including HPV GBMSM and the accelerated Mpox vaccination programme (where implemented) and make arrangements to deliver to the eligible population accessing their services from August 2025. Providers should be offering both vaccines by no later than 01 September 2025. Provider Eligibility Criteria: Eligible providers must: * Hold a current Local Authority contract for the delivery of Sexual Health Services for one or more of the Lots/Localities as identified in this procurement process. * Pass all questions within the Regulation 20 questionnaire parts 1 and part 2 and the associated quality and financial stability assessment in part 3 of the questionnaire. Contract Term: To commence in August 2025 and providers should be offering both vaccines by no later than 01 September 2025. The contract term will be co-terminus with the Local Authority contract for Sexual Health Services as highlighted for each Location/Lot which includes any permissible extension periods which would be subject to the enactment of the Local Authority: Location/Lot: Yorkshire & Humber: * Lot 9 - Doncaster - service to commence by 01 September with an expiry 30 September 2027.",
"awardCriteria": {
"criteria": [
{
"name": "Patient Choice",
"type": "quality",
"description": "100"
},
{
"name": "Patient Choice",
"type": "cost",
"description": "100"
}
]
},
"hasOptions": true,
"options": {
"description": "The contract term will be co-terminus with the Local Authority contract for Sexual Health Services as highlighted for each Location/Lot which includes any permissible extension periods which would be subject to the enactment of the Local Authority: Lot 9 - Doncaster - service to commence by 01 September with an expiry 30 September 2027."
},
"status": "cancelled"
},
{
"id": "10",
"title": "Lot 10 - Newcastle Upon Tyne",
"description": "NHS England - North East and Yorkshire (the Relevant Authority) intends to award these contracts under the Direct Award Process B under the Health Care Services (Provider Selection Regime) regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to these awards. Following the government's acceptance of the Joint Committee on Vaccination and Immunisation (JCVI) advice that the NHS should implement: * a routine mpox pre-exposure vaccination programme building on the existing offer JCVI statement on mpox vaccination as a routine programme - GOV.UK * a routine opportunistic gonorrhoea vaccination programme JCVI advice on the use of meningococcal B vaccination for the prevention of gonorrhoea - GOV.UK The Relevant Authority is now seeking suitable providers by no later than 01 September 2025 necsu.psrprocurement@nhs.net to deliver the vaccinations alongside existing vaccination programmes (HPV GBMSM) delivered in place-based Local Authority commissioned sexual health services. Providers must deliver sexual health services in identified localities and work with partners to ensure effective programme coverage and equity of access to the local eligible population. Eligibility The JCVI advised that the vaccination programmes, which have similar eligibility criteria, should primarily target gay, bisexual and other men who have sex with men (GBMSM) who meet the eligibility criteria and are at highest risk of exposure to Mpox and Gonorrhoea. There may also be a small number of individuals other than GBMSM with a similar risk of infection as the eligible GBMSM groups who can be offered the vaccines. Individuals should be identified through sexual health services using markers of high risk of infection. This includes a recent history of multiple sexual partners or recent bacterial sexually transmitted infection. Full details on the eligible cohorts for each programme are available in the service specifications for each programme. Activity/funding Funding of PS10.06 will be provided for each dose of vaccine delivered to members of the identified cohort. An additional PS8.00 per vaccination delivered will be provided in 2025/26 to support mobilisation. This additional implementation payment will be reviewed in advance of 2026/27 contract year. As these are newly developed programmes, no baseline activity level for these vaccinations is available. Activity delivered in 2025/26 will be used to determine an Indicative Activity Plan for 2026/27 and future contract years. Delivery date Providers should build on the existing delivery of vaccinations including HPV GBMSM and the accelerated Mpox vaccination programme (where implemented) and make arrangements to deliver to the eligible population accessing their services from August 2025. Providers should be offering both vaccines by no later than 01 September 2025. Provider Eligibility Criteria: Eligible providers must: * Hold a current Local Authority contract for the delivery of Sexual Health Services for one or more of the Lots/Localities as identified in this procurement process. * Pass all questions within the Regulation 20 questionnaire parts 1 and part 2 and the associated quality and financial stability assessment in part 3 of the questionnaire. Contract Term: To commence in August 2025 and providers should be offering both vaccines by no later than 01 September 2025. The contract term will be co-terminus with the Local Authority contract for Sexual Health Services as highlighted for each Location/Lot which includes any permissible extension periods which would be subject to the enactment of the Local Authority: Location/Lot: North East and North Cumbria: * Lot 10 - Newcastle Upon Tyne - service to commence by 01 September expiry 30 September 2030.",
"awardCriteria": {
"criteria": [
{
"name": "Patient Choice",
"type": "quality",
"description": "100"
},
{
"name": "Patient Choice",
"type": "cost",
"description": "100"
}
]
},
"hasOptions": true,
"options": {
"description": "The contract term will be co-terminus with the Local Authority contract for Sexual Health Services as highlighted for each Location/Lot which includes any permissible extension periods which would be subject to the enactment of the Local Authority: Lot 10 - Newcastle Upon Tyne - service to commence by 01 September expiry 30 September 2030."
},
"status": "cancelled"
}
],
"items": [
{
"id": "1",
"additionalClassifications": [
{
"scheme": "CPV",
"id": "85140000",
"description": "Miscellaneous health services"
}
],
"deliveryAddresses": [
{
"region": "UKE13"
}
],
"deliveryLocation": {
"description": "Lot 1 - North Lincolnshire and North East Lincolnshire"
},
"relatedLot": "1"
},
{
"id": "2",
"additionalClassifications": [
{
"scheme": "CPV",
"id": "85140000",
"description": "Miscellaneous health services"
}
],
"deliveryAddresses": [
{
"region": "UKE11"
}
],
"deliveryLocation": {
"description": "Lot 2 - Hull"
},
"relatedLot": "2"
},
{
"id": "3",
"additionalClassifications": [
{
"scheme": "CPV",
"id": "85140000",
"description": "Miscellaneous health services"
}
],
"deliveryAddresses": [
{
"region": "UKE12"
}
],
"deliveryLocation": {
"description": "Lot 3 - East Riding"
},
"relatedLot": "3"
},
{
"id": "4",
"additionalClassifications": [
{
"scheme": "CPV",
"id": "85140000",
"description": "Miscellaneous health services"
}
],
"deliveryAddresses": [
{
"region": "UKE42"
}
],
"deliveryLocation": {
"description": "Lot 4 - Leeds"
},
"relatedLot": "4"
},
{
"id": "5",
"additionalClassifications": [
{
"scheme": "CPV",
"id": "85140000",
"description": "Miscellaneous health services"
}
],
"deliveryAddresses": [
{
"region": "UKE41"
}
],
"deliveryLocation": {
"description": "Lot 5 - Bradford"
},
"relatedLot": "5"
},
{
"id": "6",
"additionalClassifications": [
{
"scheme": "CPV",
"id": "85140000",
"description": "Miscellaneous health services"
}
],
"deliveryAddresses": [
{
"region": "UKE4"
}
],
"deliveryLocation": {
"description": "Lot 6 - Kirklees"
},
"relatedLot": "6"
},
{
"id": "7",
"additionalClassifications": [
{
"scheme": "CPV",
"id": "85140000",
"description": "Miscellaneous health services"
}
],
"deliveryAddresses": [
{
"region": "UKE45"
}
],
"deliveryLocation": {
"description": "Lot 7 - Wakefield"
},
"relatedLot": "7"
},
{
"id": "8",
"additionalClassifications": [
{
"scheme": "CPV",
"id": "85140000",
"description": "Miscellaneous health services"
}
],
"deliveryAddresses": [
{
"region": "UKE31"
}
],
"deliveryLocation": {
"description": "Lot 8 - Barnsley"
},
"relatedLot": "8"
},
{
"id": "9",
"additionalClassifications": [
{
"scheme": "CPV",
"id": "85140000",
"description": "Miscellaneous health services"
}
],
"deliveryAddresses": [
{
"region": "UKE31"
}
],
"deliveryLocation": {
"description": "Lot 9 - Doncaster"
},
"relatedLot": "9"
},
{
"id": "10",
"additionalClassifications": [
{
"scheme": "CPV",
"id": "85140000",
"description": "Miscellaneous health services"
}
],
"deliveryAddresses": [
{
"region": "UKC22"
}
],
"deliveryLocation": {
"description": "Lot 10 - Newcastle Upon Tyne"
},
"relatedLot": "10"
}
],
"procurementMethod": "limited",
"procurementMethodDetails": "Award procedure without prior publication of a call for competition",
"coveredBy": [
"GPA"
],
"procurementMethodRationaleClassifications": [
{
"scheme": "TED_PT_AWARD_CONTRACT_WITHOUT_CALL",
"id": "D_OUTSIDE_SCOPE",
"description": "The procurement falls outside the scope of application of the directive"
}
],
"procurementMethodRationale": "The Relevant Authority intends to award this contract under the Direct Award Process B under the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award. There were no Conflicts of Interest."
},
"awards": [
{
"id": "052590-2025-Lot 1 - North Lincolnshire and North East Lincolnshire-1",
"title": "NHSE1088 - Mpox Vaccination and Gonorrhoea Vaccination",
"status": "active",
"suppliers": [
{
"id": "GB-NHS-RY5",
"name": "Lincolnshire Community Health Services NHS Trust"
}
]
},
{
"id": "052590-2025-Lot 2 - Hull-2",
"title": "NHSE1088 - Mpox Vaccination and Gonorrhoea Vaccination",
"status": "active",
"suppliers": [
{
"id": "GB-COH-06273905",
"name": "City Health Care Partnership CIC"
}
]
},
{
"id": "052590-2025-Lot 3 - East Riding-3",
"title": "NHSE1088 - Mpox Vaccination and Gonorrhoea Vaccination",
"status": "active",
"suppliers": [
{
"id": "GB-COH-06273905",
"name": "City Health Care Partnership CIC"
}
]
},
{
"id": "052590-2025-Lot 4 - Leeds-4",
"title": "NHSE1088 - Mpox Vaccination and Gonorrhoea Vaccination",
"status": "active",
"suppliers": [
{
"id": "GB-NHS-RY6",
"name": "Leeds Community Healthcare NHS Trust"
}
]
},
{
"id": "052590-2025-Lot 5 - Bradford-5",
"title": "NHSE1088 - Mpox Vaccination and Gonorrhoea Vaccination",
"status": "active",
"suppliers": [
{
"id": "GB-COH-07584906",
"name": "Locala Community Partnerships CIC"
}
]
},
{
"id": "052590-2025-Lot 6 - Kirklees-6",
"title": "NHSE1088 - Mpox Vaccination and Gonorrhoea Vaccination",
"status": "active",
"suppliers": [
{
"id": "GB-COH-07584906",
"name": "Locala Community Partnerships CIC"
}
]
},
{
"id": "052590-2025-Lot 7 - Wakefield-7",
"title": "NHSE1088 - Mpox Vaccination and Gonorrhoea Vaccination",
"status": "active",
"suppliers": [
{
"id": "GB-COH-07300133",
"name": "Spectrum Community Health CIC"
}
]
},
{
"id": "052590-2025-Lot 8 - Barnsley-8",
"title": "NHSE1088 - Mpox Vaccination and Gonorrhoea Vaccination",
"status": "active",
"suppliers": [
{
"id": "GB-COH-07300133",
"name": "Spectrum Community Health CIC"
}
]
},
{
"id": "052590-2025-Lot 9 - Doncaster-9",
"title": "NHSE1088 - Mpox Vaccination and Gonorrhoea Vaccination",
"status": "active",
"suppliers": [
{
"id": "GB-COH-06475161",
"name": "Solutions 4 Health"
}
]
},
{
"id": "052590-2025-Lot 10 - Newcastle Upon Tyne-10",
"title": "NHSE1088 - Mpox Vaccination and Gonorrhoea Vaccination",
"status": "active",
"suppliers": [
{
"id": "GB-COH-06475161",
"name": "Solutions 4 Health"
}
]
}
],
"parties": [
{
"id": "GB-NHS-(Q72)",
"name": "NHS England North East And Yorkshire",
"identifier": {
"legalName": "NHS England North East And Yorkshire",
"id": "(Q72)",
"scheme": "GB-NHS"
},
"address": {
"streetAddress": "City Office Park 3 Leeds City Office Park Holbeck",
"locality": "Leeds",
"region": "UKE",
"postalCode": "LS11 5BD",
"countryName": "United Kingdom"
},
"contactPoint": {
"email": "necsu.psrprocurement@nhs.net"
},
"roles": [
"buyer"
],
"details": {
"url": "https://www.england.nhs.uk/north-east-yorkshire/",
"classifications": [
{
"scheme": "TED_CA_TYPE",
"id": "BODY_PUBLIC",
"description": "Body governed by public law"
},
{
"scheme": "COFOG",
"id": "07",
"description": "Health"
}
]
}
},
{
"id": "GB-NHS-RY5",
"name": "Lincolnshire Community Health Services NHS Trust",
"identifier": {
"legalName": "Lincolnshire Community Health Services NHS Trust",
"id": "RY5",
"scheme": "GB-NHS"
},
"address": {
"streetAddress": "Beech House, Witham Park, Waterside South",
"locality": "Lincoln",
"region": "UKE13",
"postalCode": "LN5 7JH",
"countryName": "United Kingdom"
},
"roles": [
"supplier"
],
"details": {
"url": "https://lincolnshirecommunityhealthservices.nhs.uk/contact-us",
"scale": "large"
}
},
{
"id": "GB-COH-06273905",
"name": "City Health Care Partnership CIC",
"identifier": {
"legalName": "City Health Care Partnership CIC",
"id": "06273905",
"scheme": "GB-COH"
},
"address": {
"streetAddress": "5 Beacon Way",
"locality": "Hull",
"region": "UKE11",
"postalCode": "HU3 4AE",
"countryName": "United Kingdom"
},
"roles": [
"supplier"
],
"details": {
"url": "https://www.chcpcic.org.uk/pages/head-office",
"scale": "large"
}
},
{
"id": "GB-NHS-RY6",
"name": "Leeds Community Healthcare NHS Trust",
"identifier": {
"legalName": "Leeds Community Healthcare NHS Trust",
"id": "RY6",
"scheme": "GB-NHS"
},
"address": {
"streetAddress": "White Rose Office Park, Building 3 Millshaw Park Lane",
"locality": "Leeds",
"region": "UKE42",
"postalCode": "LS11 0DL",
"countryName": "United Kingdom"
},
"roles": [
"supplier"
],
"details": {
"url": "https://leedscommunityhealthcare.nhs.uk/contact-us/",
"scale": "large"
}
},
{
"id": "GB-COH-07584906",
"name": "Locala Community Partnerships CIC",
"identifier": {
"legalName": "Locala Community Partnerships CIC",
"id": "07584906",
"scheme": "GB-COH"
},
"address": {
"streetAddress": "Eddercliffe Health Centre, Bradford Road,",
"locality": "Liversedge",
"region": "UKE4",
"postalCode": "WF15 6LP",
"countryName": "United Kingdom"
},
"roles": [
"supplier"
],
"details": {
"url": "https://www.locala.org.uk/",
"scale": "large"
}
},
{
"id": "GB-COH-07300133",
"name": "Spectrum Community Health CIC",
"identifier": {
"legalName": "Spectrum Community Health CIC",
"id": "07300133",
"scheme": "GB-COH"
},
"address": {
"streetAddress": "1 Navigation Walk, Hebble Wharf,",
"locality": "Wakefield",
"region": "UKE45",
"postalCode": "WF1 5RH",
"countryName": "United Kingdom"
},
"roles": [
"supplier"
],
"details": {
"url": "https://spectrum-cic.org.uk/",
"scale": "large"
}
},
{
"id": "GB-COH-06475161",
"name": "Solutions 4 Health",
"identifier": {
"legalName": "Solutions 4 Health",
"id": "06475161",
"scheme": "GB-COH"
},
"address": {
"streetAddress": "Head Office Unit 1 Thames Court Richfield Avenue",
"locality": "Reading",
"region": "UKJ1",
"postalCode": "RG1 8EQ",
"countryName": "United Kingdom"
},
"roles": [
"supplier"
],
"details": {
"url": "https://www.solutions4health.co.uk/about-us/",
"scale": "large"
}
},
{
"id": "GB-FTS-159290",
"name": "NHS England North East And Yorkshire",
"identifier": {
"legalName": "NHS England North East And Yorkshire"
},
"address": {
"streetAddress": "City Office Park 3 Leeds City Office Park Holbeck",
"locality": "Leeds",
"postalCode": "LS11 5BD",
"countryName": "United Kingdom"
},
"contactPoint": {
"email": "necsu.psrprocurement@nhs.net"
},
"roles": [
"reviewBody"
],
"details": {
"url": "https://www.england.nhs.uk/north-east-yorkshire/"
}
}
],
"buyer": {
"id": "GB-NHS-(Q72)",
"name": "NHS England North East And Yorkshire"
},
"contracts": [
{
"id": "052590-2025-Lot 1 - North Lincolnshire and North East Lincolnshire-1",
"awardID": "052590-2025-Lot 1 - North Lincolnshire and North East Lincolnshire-1",
"title": "NHSE1088 - Mpox Vaccination and Gonorrhoea Vaccination",
"status": "active",
"dateSigned": "2025-08-20T00:00:00+01:00"
},
{
"id": "052590-2025-Lot 2 - Hull-2",
"awardID": "052590-2025-Lot 2 - Hull-2",
"title": "NHSE1088 - Mpox Vaccination and Gonorrhoea Vaccination",
"status": "active",
"dateSigned": "2025-08-20T00:00:00+01:00"
},
{
"id": "052590-2025-Lot 3 - East Riding-3",
"awardID": "052590-2025-Lot 3 - East Riding-3",
"title": "NHSE1088 - Mpox Vaccination and Gonorrhoea Vaccination",
"status": "active",
"dateSigned": "2025-08-20T00:00:00+01:00"
},
{
"id": "052590-2025-Lot 4 - Leeds-4",
"awardID": "052590-2025-Lot 4 - Leeds-4",
"title": "NHSE1088 - Mpox Vaccination and Gonorrhoea Vaccination",
"status": "active",
"dateSigned": "2025-08-20T00:00:00+01:00"
},
{
"id": "052590-2025-Lot 5 - Bradford-5",
"awardID": "052590-2025-Lot 5 - Bradford-5",
"title": "NHSE1088 - Mpox Vaccination and Gonorrhoea Vaccination",
"status": "active",
"dateSigned": "2025-08-20T00:00:00+01:00"
},
{
"id": "052590-2025-Lot 6 - Kirklees-6",
"awardID": "052590-2025-Lot 6 - Kirklees-6",
"title": "NHSE1088 - Mpox Vaccination and Gonorrhoea Vaccination",
"status": "active",
"dateSigned": "2025-08-20T00:00:00+01:00"
},
{
"id": "052590-2025-Lot 7 - Wakefield-7",
"awardID": "052590-2025-Lot 7 - Wakefield-7",
"title": "NHSE1088 - Mpox Vaccination and Gonorrhoea Vaccination",
"status": "active",
"dateSigned": "2025-08-20T00:00:00+01:00"
},
{
"id": "052590-2025-Lot 8 - Barnsley-8",
"awardID": "052590-2025-Lot 8 - Barnsley-8",
"title": "NHSE1088 - Mpox Vaccination and Gonorrhoea Vaccination",
"status": "active",
"dateSigned": "2025-08-20T00:00:00+01:00"
},
{
"id": "052590-2025-Lot 9 - Doncaster-9",
"awardID": "052590-2025-Lot 9 - Doncaster-9",
"title": "NHSE1088 - Mpox Vaccination and Gonorrhoea Vaccination",
"status": "active",
"dateSigned": "2025-08-20T00:00:00+01:00"
},
{
"id": "052590-2025-Lot 10 - Newcastle Upon Tyne-10",
"awardID": "052590-2025-Lot 10 - Newcastle Upon Tyne-10",
"title": "NHSE1088 - Mpox Vaccination and Gonorrhoea Vaccination",
"status": "active",
"dateSigned": "2025-08-20T00:00:00+01:00"
}
],
"bids": {
"statistics": [
{
"id": "5",
"measure": "bids",
"value": 1
},
{
"id": "8",
"measure": "bids",
"value": 1
},
{
"id": "11",
"measure": "bids",
"value": 1
},
{
"id": "14",
"measure": "bids",
"value": 1
},
{
"id": "17",
"measure": "bids",
"value": 1
},
{
"id": "20",
"measure": "bids",
"value": 1
},
{
"id": "23",
"measure": "bids",
"value": 1
},
{
"id": "26",
"measure": "bids",
"value": 1
},
{
"id": "29",
"measure": "bids",
"value": 1
},
{
"id": "32",
"measure": "bids",
"value": 1
},
{
"id": "3",
"measure": "lowestValidBidValue",
"value": 0.01,
"currency": "GBP"
},
{
"id": "6",
"measure": "lowestValidBidValue",
"value": 0.01,
"currency": "GBP"
},
{
"id": "9",
"measure": "lowestValidBidValue",
"value": 0.01,
"currency": "GBP"
},
{
"id": "12",
"measure": "lowestValidBidValue",
"value": 0.01,
"currency": "GBP"
},
{
"id": "15",
"measure": "lowestValidBidValue",
"value": 0.01,
"currency": "GBP"
},
{
"id": "18",
"measure": "lowestValidBidValue",
"value": 0.01,
"currency": "GBP"
},
{
"id": "21",
"measure": "lowestValidBidValue",
"value": 0.01,
"currency": "GBP"
},
{
"id": "24",
"measure": "lowestValidBidValue",
"value": 0.01,
"currency": "GBP"
},
{
"id": "27",
"measure": "lowestValidBidValue",
"value": 0.01,
"currency": "GBP"
},
{
"id": "30",
"measure": "lowestValidBidValue",
"value": 0.01,
"currency": "GBP"
},
{
"id": "4",
"measure": "highestValidBidValue",
"value": 18.06,
"currency": "GBP"
},
{
"id": "7",
"measure": "highestValidBidValue",
"value": 18.06,
"currency": "GBP"
},
{
"id": "10",
"measure": "highestValidBidValue",
"value": 18.06,
"currency": "GBP"
},
{
"id": "13",
"measure": "highestValidBidValue",
"value": 18.06,
"currency": "GBP"
},
{
"id": "16",
"measure": "highestValidBidValue",
"value": 18.06,
"currency": "GBP"
},
{
"id": "19",
"measure": "highestValidBidValue",
"value": 18.06,
"currency": "GBP"
},
{
"id": "22",
"measure": "highestValidBidValue",
"value": 18.06,
"currency": "GBP"
},
{
"id": "25",
"measure": "highestValidBidValue",
"value": 18.06,
"currency": "GBP"
},
{
"id": "28",
"measure": "highestValidBidValue",
"value": 18.06,
"currency": "GBP"
},
{
"id": "31",
"measure": "highestValidBidValue",
"value": 18.06,
"currency": "GBP"
},
{
"id": "1",
"measure": "lowestValidBidValue",
"value": 0.01,
"currency": "GBP"
},
{
"id": "2",
"measure": "highestValidBidValue",
"value": 18.06,
"currency": "GBP"
}
]
},
"language": "en"
}